Atlas Trials

Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males

Clinical trial NCT00540553 · COMPLETED

Trial details

NCT number
NCT00540553
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy SubjectsAndrogen Deficiency
Start date
2007-08-01
Primary completion
2008-04-01
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.